MarketPeel
Pricing
…
Chief Financial Officer
Edward J. III Dulac
Mon, Dec 20, 2021
Dec 20
exercised or converted securities in FATE
14,437 shares @ $35.52
Increased holdings by +12.90%
Net across this filing: -1.40% (-1,540 shares)
Option Exercise
Sale tied to a same-time option exercise
FATEFATE THERAPEUTICS INC
HealthcareBiotechnology
1D0.00%
1W-6.49%
1M+1.66%
3M+13.95%
6M—
1Y—

Recent insider activity at FATE

Aug 4Bahram ValamehrSold$108.10kAug 4Cindy TahlSold$95.41kMay 20Bahram ValamehrSold$54.48kMay 20Cindy TahlSold$48.08kJan 9Cindy TahlSold$11.28kJan 9Bahram ValamehrSold$5.56kAug 4Cindy TahlSold$9.57kAug 4Bahram ValamehrSold$15.40k
Full FATE profile →Edward J. III Dulac’s trading history →
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback